Feb 15, 2013, 01.52 AM | Source: PTI
Country's second largest software services firm Infosys today said it has received approval for listing of its American Depositary Shares (ADS) on NYSE Euronext Paris.
"The French Autorité des marchés financiers (AMF) the French Financial Markets Authority -- has approved the company's prospectus for admission of its ADS for listing and trading on the professional segment of NYSE Euronext Paris, and has granted visa number 13-029, dated February 13, 2013, on the prospectus," Infosys said in a statement.
Infosys has also applied for admission to listing and trading on NYSE Euronext London.
On February 12, 2013, Euronext Paris S.A. approved Infosys' application for listing and trading its ADS on NYSE Euronext Paris, and LIFFE Administration and Management approved its application for trading of its ADS on NYSE Euronext London.
Infosys, which made an application for admission of its ADS to the Official List of the UK Listing Authority (UKLA), expects UKLA's approval following a listing hearing on the tentative date of February 18, 2013.
Infosys' ADS are scheduled to begin trading on the Euronext exchanges and to be admitted to the Official List of the UKLA on February 20, 2013.
The ADS will trade under the symbol 'INFY' and be denominated in euros on the Euronext exchanges.
"This listing will not alter Infosys' share count, capital structure, or current stock listing on the New York Stock Exchange (NYSE), where it also trades under the symbol 'INFY', it said.
The Euronext listings are intended to attract investors based outside of India and the US, particularly in Europe, to provide greater access to Infosys' ADS among European fund managers.
Infosys stock price
On May 27, 2016, Infosys closed at Rs 1246.40, up Rs 14.75, or 1.20 percent. The 52-week high of the share was Rs 1267.90 and the 52-week low was Rs 932.55.
The company's trailing 12-month (TTM) EPS was at Rs 68.72 per share as per the quarter ended March 2016. The stock's price-to-earnings (P/E) ratio was 18.14. The latest book value of the company is Rs 209.27 per share. At current value, the price-to-book value of the company is 5.96.
Ashwani Gujral of ashwanigujral.com recommends buy
Sudarshan Sukhani of s2analytics.com is of the vie
R Sreesankar, Head Institutional Equities, Prabhud
Infosys Ltd has informed BSE that the Annual Gener
According to Sudarshan Sukhani of s2analytics.com,
HeidelbergCement India has reported a sales turnov
Medi-Caps has reported a sales turnover of Rs 6.77